SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-078800
Filing Date
2024-03-27
Accepted
2024-03-27 16:08:00
Documents
15
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807451d8k.htm   iXBRL 8-K 28891
2 EX-99.1 d807451dex991.htm EX-99.1 81480
  Complete submission text file 0001193125-24-078800.txt   297448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mreo-20240327.xsd EX-101.SCH 4136
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20240327_def.xml EX-101.DEF 15189
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20240327_lab.xml EX-101.LAB 25307
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20240327_pre.xml EX-101.PRE 16157
18 EXTRACTED XBRL INSTANCE DOCUMENT d807451d8k_htm.xml XML 6726
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38452 | Film No.: 24790650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)